Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema [Phase 3]
A Phase 3 trial evaluating the combination of intravitreal fasudil and bevacizumab for diabetic macular edema has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy [Phase 1]
A Phase 1 clinical trial of SAR 1118 in patients undergoing pars plana vitrectomy for diabetic macular edema was terminated.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study [Phase 2]
Phase 2 READ 3 study assessing high-dose ranibizumab for diabetic macular edema has completed, with results posted.
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: 24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME. [Phase 4]
A Phase 4 trial comparing systemic VEGF levels after ranibizumab versus aflibercept in diabetic macular edema was withdrawn.
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: OCT-angiography in Diabetic Patients
Clinical trial update on the use of OCT-angiography in diabetic patients with Diabetic Macular Edema. The current status of the trial is unk…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Autofluorescence in Uveitic and Diabetic Macular Edema
A clinical trial assessing autofluorescence in uveitic and diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of the OZURDEX dexamethasone intravitreal implant in patients with diabetic macular edema…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study [Phase 2]
The READ-2 Phase 2 trial evaluated ranibizumab for diabetic macular edema; the study has completed and results were posted in 2017.
-
CLINICAL_TRIALS research · 2017-03-28Clinical Trial Update: The Relationship Between Intraocular Pressure and Macular Edema in Patients With Diabetic Macular Edema [NA]
A clinical trial update examining the relationship between intraocular pressure and macular edema in patients with diabetic macular edema.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema [Phase 4]
Phase 4 clinical trial update evaluating aflibercept (Eylea) for bevacizumab-resistant diabetic macular edema.
-
CLINICAL_TRIALS research · 2017-03-21Clinical Trial Update: Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada
This clinical trial update reports on evaluating how well physicians understand safety and safe-use information for aflibercept (Eylea) in C…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema [Phase 2]
The TIME-2 Phase 2 trial of AKB-9778, a Tie-2 activator, for diabetic macular edema has completed.
-
CLINICAL_TRIALS research · 2017-03-13Clinical Trial Update: Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)
A completed clinical trial update investigating why eyes with diabetic macular edema respond differently to intravitreal anti-VEGF therapy.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients [Phase 4]
Phase 4 pilot trial evaluating the effectiveness and safety of Iluvien for chronic diabetic macular edema.
-
FDA approval · 2017-03-08FDA Approved: ILUVIEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for ILUVIEN (fluocinolone acetonide) submitted by ANI Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME [Phase 1]
The document reports the completion of a Phase I single ascending dose study of intravitreal KVD001 in subjects with diabetic macular edema.
-
CLINICAL_TRIALS research · 2017-03-01Clinical Trial Update: Observation of Treatment Patterns With Lucentis in Approved Indications
An observational study examining how Lucentis is used in approved indications such as neovascular age-related macular degeneration and diabe…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone [Phase 3]
Phase 3 multicentre randomized trial comparing fixed versus PRN dosing of a 700 μg dexamethasone intravitreal implant for diabetic macular e…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema [Phase 4]
Phase 4 trial evaluating the efficacy and safety of ranibizumab 0.5 mg in diabetic patients with visual impairment due to macular edema. The…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Ranibizumab "Treat and Extend" in Diabetic Macular Edma [Phase 4]
This Phase 4 trial evaluates a treat-and-extend dosing strategy of ranibizumab for diabetic macular edema; the study has completed.
-
CLINICAL_TRIALS research · 2017-02-23Clinical Trial Update: Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema [Phase 4]
Phase 4 trial update evaluating the combination of Lucentis (ranibizumab) therapy with micropulse diode laser for diabetic macular edema. Th…
-
FDA approval · 2017-01-05FDA Approved: LUCENTIS — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for LUCENTIS (ranibizumab) from Genentech, Inc., modifying the existing approval.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema [Phase 2]
Phase 2 trial evaluating the effects of Darapladib in subjects with Diabetic Macular Edema has completed.
-
CLINICAL_TRIALS withdrawal · 2016-10-27Clinical Trial Update: Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema [Phase 4]
Phase 4 trial evaluating systemic VEGF protein dynamics after intravitreal ranibizumab versus aflibercept in patients with diabetic macular …
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection
The study explored how the vitreomacular interface affects progression of diabetic macular edema following anti-VEGF injections.